Cargando…
Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study
Generative adversarial networks (GANs) can synthesize high-contrast MRI from lower-contrast input. Targeted translation of parenchymal lesions in multiple sclerosis (MS), as well as visualization of model confidence further augment their utility, provided that the GAN generalizes reliably across dif...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087732/ https://www.ncbi.nlm.nih.gov/pubmed/35557607 http://dx.doi.org/10.3389/fnins.2022.889808 |
_version_ | 1784704226814853120 |
---|---|
author | Finck, Tom Li, Hongwei Schlaeger, Sarah Grundl, Lioba Sollmann, Nico Bender, Benjamin Bürkle, Eva Zimmer, Claus Kirschke, Jan Menze, Björn Mühlau, Mark Wiestler, Benedikt |
author_facet | Finck, Tom Li, Hongwei Schlaeger, Sarah Grundl, Lioba Sollmann, Nico Bender, Benjamin Bürkle, Eva Zimmer, Claus Kirschke, Jan Menze, Björn Mühlau, Mark Wiestler, Benedikt |
author_sort | Finck, Tom |
collection | PubMed |
description | Generative adversarial networks (GANs) can synthesize high-contrast MRI from lower-contrast input. Targeted translation of parenchymal lesions in multiple sclerosis (MS), as well as visualization of model confidence further augment their utility, provided that the GAN generalizes reliably across different scanners. We here investigate the generalizability of a refined GAN for synthesizing high-contrast double inversion recovery (DIR) images and propose the use of uncertainty maps to further enhance its clinical utility and trustworthiness. A GAN was trained to synthesize DIR from input fluid-attenuated inversion recovery (FLAIR) and T1w of 50 MS patients (training data). In another 50 patients (test data), two blinded readers (R1 and R2) independently quantified lesions in synthetic DIR (synthDIR), acquired DIR (trueDIR) and FLAIR. Of the 50 test patients, 20 were acquired on the same scanner as training data (internal data), while 30 were scanned at different scanners with heterogeneous field strengths and protocols (external data). Lesion-to-Background ratios (LBR) for MS-lesions vs. normal appearing white matter, as well as image quality parameters were calculated. Uncertainty maps were generated to visualize model confidence. Significantly more MS-specific lesions were found in synthDIR compared to FLAIR (R1: 26.7 ± 2.6 vs. 22.5 ± 2.2 p < 0.0001; R2: 22.8 ± 2.2 vs. 19.9 ± 2.0, p = 0.0005). While trueDIR remained superior to synthDIR in R1 [28.6 ± 2.9 vs. 26.7 ± 2.6 (p = 0.0021)], both sequences showed comparable lesion conspicuity in R2 [23.3 ± 2.4 vs. 22.8 ± 2.2 (p = 0.98)]. Importantly, improvements in lesion counts were similar in internal and external data. Measurements of LBR confirmed that lesion-focused GAN training significantly improved lesion conspicuity. The use of uncertainty maps furthermore helped discriminate between MS lesions and artifacts. In conclusion, this multicentric study confirms the external validity of a lesion-focused Deep-Learning tool aimed at MS imaging. When implemented, uncertainty maps are promising to increase the trustworthiness of synthetic MRI. |
format | Online Article Text |
id | pubmed-9087732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90877322022-05-11 Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study Finck, Tom Li, Hongwei Schlaeger, Sarah Grundl, Lioba Sollmann, Nico Bender, Benjamin Bürkle, Eva Zimmer, Claus Kirschke, Jan Menze, Björn Mühlau, Mark Wiestler, Benedikt Front Neurosci Neuroscience Generative adversarial networks (GANs) can synthesize high-contrast MRI from lower-contrast input. Targeted translation of parenchymal lesions in multiple sclerosis (MS), as well as visualization of model confidence further augment their utility, provided that the GAN generalizes reliably across different scanners. We here investigate the generalizability of a refined GAN for synthesizing high-contrast double inversion recovery (DIR) images and propose the use of uncertainty maps to further enhance its clinical utility and trustworthiness. A GAN was trained to synthesize DIR from input fluid-attenuated inversion recovery (FLAIR) and T1w of 50 MS patients (training data). In another 50 patients (test data), two blinded readers (R1 and R2) independently quantified lesions in synthetic DIR (synthDIR), acquired DIR (trueDIR) and FLAIR. Of the 50 test patients, 20 were acquired on the same scanner as training data (internal data), while 30 were scanned at different scanners with heterogeneous field strengths and protocols (external data). Lesion-to-Background ratios (LBR) for MS-lesions vs. normal appearing white matter, as well as image quality parameters were calculated. Uncertainty maps were generated to visualize model confidence. Significantly more MS-specific lesions were found in synthDIR compared to FLAIR (R1: 26.7 ± 2.6 vs. 22.5 ± 2.2 p < 0.0001; R2: 22.8 ± 2.2 vs. 19.9 ± 2.0, p = 0.0005). While trueDIR remained superior to synthDIR in R1 [28.6 ± 2.9 vs. 26.7 ± 2.6 (p = 0.0021)], both sequences showed comparable lesion conspicuity in R2 [23.3 ± 2.4 vs. 22.8 ± 2.2 (p = 0.98)]. Importantly, improvements in lesion counts were similar in internal and external data. Measurements of LBR confirmed that lesion-focused GAN training significantly improved lesion conspicuity. The use of uncertainty maps furthermore helped discriminate between MS lesions and artifacts. In conclusion, this multicentric study confirms the external validity of a lesion-focused Deep-Learning tool aimed at MS imaging. When implemented, uncertainty maps are promising to increase the trustworthiness of synthetic MRI. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9087732/ /pubmed/35557607 http://dx.doi.org/10.3389/fnins.2022.889808 Text en Copyright © 2022 Finck, Li, Schlaeger, Grundl, Sollmann, Bender, Bürkle, Zimmer, Kirschke, Menze, Mühlau and Wiestler. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Finck, Tom Li, Hongwei Schlaeger, Sarah Grundl, Lioba Sollmann, Nico Bender, Benjamin Bürkle, Eva Zimmer, Claus Kirschke, Jan Menze, Björn Mühlau, Mark Wiestler, Benedikt Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study |
title | Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study |
title_full | Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study |
title_fullStr | Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study |
title_full_unstemmed | Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study |
title_short | Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study |
title_sort | uncertainty-aware and lesion-specific image synthesis in multiple sclerosis magnetic resonance imaging: a multicentric validation study |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087732/ https://www.ncbi.nlm.nih.gov/pubmed/35557607 http://dx.doi.org/10.3389/fnins.2022.889808 |
work_keys_str_mv | AT fincktom uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT lihongwei uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT schlaegersarah uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT grundllioba uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT sollmannnico uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT benderbenjamin uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT burkleeva uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT zimmerclaus uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT kirschkejan uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT menzebjorn uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT muhlaumark uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy AT wiestlerbenedikt uncertaintyawareandlesionspecificimagesynthesisinmultiplesclerosismagneticresonanceimagingamulticentricvalidationstudy |